ARROWHEAD PHARMACEUTICALS, INC. - 8-K Filing

Arrowhead Pharmaceuticals reports fiscal 2026 year-end results and announces $400 million senior secured term loan facility. (Items: 2.02 Results of Operations and Financial Condition On November 12, 2026, Arrowhead Pharmaceuticals, Inc, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 21:01 UTC

Tickers: $ARWR

Read the full article at SEC EDGAR

More Regulatory news

Ascend Wellness Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
ON SEMICONDUCTOR CORP - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
Equillium, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
Exyn Technologies, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
Sanara MedTech Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
Invesco Galaxy Ethereum ETF - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC
PLIANT THERAPEUTICS, INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:09 UTC
Arcadia Biosciences, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 21:09 UTC
US Foods Holding Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 21:09 UTC
MARZETTI CO - 8-K Filing SEC EDGAR · November 12, 2026, 21:10 UTC